THE Therapeutic Goods
Administration says an analysis of
Slimina weightloss capsules shows
the products contain therapeutic
quantities of sibutramine.
The TGA said it’s aware that some
Australian consumers may have
bought the unapproved product
over the internet.
Prescription-only sibutramine was
withdrawn from sale in Australia in
Oct 2010 due to safety concerns,
and the TGA advised consumers to
stop using the capsules and discard
any remaining product.
“Consumers are again advised to
exercise extreme caution about
purchasing medicines from
unknown overseas internet sites,”
the TGA said in a statement.The above article was sent to subscribers in Pharmacy Daily's issue from 19 Aug 11 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Aug 11
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
AUSTRALIA’S public hospitals are facing their lengthiest wait times on record for planned surgeries, with emergency departments struggling under access blockages, according to the latest annual Public Hospital Report Card by the Australian Medical Association (AMA).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.